Principles and Applications of Pharmacogenomics

Alain Li wan Po is pharmacy lead at the NHS National Genetics Education and Development Centre in Birmingham. He has held professorships in pharmaceutics and clinical pharmaceutics at Queen's University of Belfast and at the universities of Nottingham and Aston.

Section 1. Chapter 1 Historical Perspectives and the promise of personalized therapy. Chapter 2 Causes of variability in human drug response. Chapter 3 Genes and the Human Genome. Chapter 4 Developing better drugs through genomics. Chapter 5 Genetically-engineered drugs. Chapter 6 Monoclonal antibodies. Chapter 7 Gene therapy. Chapter 8 Gene silencing. Chapter 9 Cell-based therapy. Chapter 10 Genetic Testing to personalise treatment. Chapter 11 Ethnicity and pharmacogenomics. Chapter 12 Paying for the fruits of pharmacogenomics research. Chapter 13 Drug Regulatory Perspectives. Chapter 14 Ethical dilemmas. Section 2. Chapter 15 Case study 1: Pharmacogenetics of cancer. Chapter 16 Case study 2: Pharmacogenetics of Schizophrenia. Chapter 17 Case study 3: Pharmacogenetics of anticoagulant therapy. Chapter 18 Case study 4: Pharmacogenetics in anaesthesia. Chapter 19 Case study 5: Pharmacogenetics of adverse drug reactions. Section 3. Chapter 20 How drugs work: introduction to drug action. Chapter 21 Polymorphisms of metabolic enzymes. Chapter 22 Polymorphisms of drug receptors and transporters. Chapter 23 Cost-effectiveness assessment in pharmacogenetics. Chapter 24 Laboratory techniques in pharmacogenetics. Chapter 25 Meta-analysis in pharmacogenetics. Chapter 26 Pharmacoepigenetics. Chapter 27 Basic statistical methods in pharmacogenomics